Shimadzu Corp. Hits Day High with Strong 4.19% Intraday Surge

Shimadzu Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, with its stock rising by 4.19% as of May 25, 2026. The stock reached an intraday high of JPY 3,876.00, reflecting a robust performance compared to the Japan Nikkei 225, which increased by 2.87% on the same day. Over the past week, Shimadzu Corp. has outperformed the Nikkei 225 with an 8.09% gain, while its one-month performance stands at 7.85%. However, the company has faced challenges over the longer term, with a year-to-date decline of 7.01% and a three-year performance down by 11.51%. Despite these fluctuations, Shimadzu maintains a strong management efficiency, evidenced by a return on equity (ROE) of 10.87% and a low debt-to-equity ratio of -0.26. The company’s market capitalization is JPY 1,137,502 million, and it currently trades at a price-to-book ratio of 2.14. While the stock has generated a return of 8.84% over the past year, it has not kept pace with the broader market, which has seen returns of 71.25%.